An important biomarker in diabetes and prediabetes testing, the assay is expected to be commercially available for use on all of Ortho’s Vitros immunodiagnostic and integrated systems in the United States during the third quarter of this year.
Read More
The companies have entered into an exclusive, multiyear partnership to employ noninvasive, lipidomics-based diagnostic testing to establish a database enriched for subjects with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Read More
Rising diabetes rates are raising concern on a global scale.
Read MoreOf the approximately 48,000 US drug overdose deaths in 2014, 26,000 were caused by prescription opioids and benzodiazepines, such as Xanax, and the remainder involved heroin.
Read More
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read More